CRYO-CELL LAUNCHES CÉLLE, FIRST-EVER PROPRIETARY MENSTRUAL
STEM CELL SERVICE
Company’s Newly Discovered Stem Cell Shows Promising Potential
in Regenerative Medicine
November 1, 2007 Cryo-Cell International Inc.,
one of the largest and most established family cord blood banks, today
announced its discovery of breakthrough stem cell technology and its launch
of the world’s first-ever service provided for women to store their
own menstrual stem cells. The new service, called CélleSM (pronounced “C-L”),
enables women to collect menstrual flow containing stem cells, which can
be cryogenically preserved in a manner similar to stem cells from umbilical
cord blood and may one day serve as a potential source for promising regenerative
therapies to treat heart disease, diabetes, neurological disorders like spinal
cord injury, Parkinson’s and Alzheimer’s diseases, in addition
to cosmeceutical applications such as anti-aging therapies, to name a few. However,
realistically, it may take several years for these menstrual stem cells to
be developed into potential widely-available commercial therapies. The
Célle service is based on Cryo-Cell’s intellectual property,
for which patent applications are pending, related to the procurement, processing,
isolation and cryo-preservation of these unique menstrual stem cells. [View Full Press Release]
